Chinese health officials began clinical trials of the antiviral drug Remdesivir on Thursday with patients with pneumonia associated with Coronavirus. Remdesivir is developed by Gilead Sciences, an American pharmaceutical company, said Cao Bin, head of the drug's clinical trial program.
This treatment had positive effects on the health of animals with other types of coronavirus. Recent studies on the drug in China have shown good reactivity against the new coronavirus (2019-nCoV).
According to the latest assessment provided by the Chinese authorities, 1400 people have died of the new coronavirus since its appearance in early December in Hubei province, while more than 65,000 others have it.
